Designing and delivering teleradiology services which meet your specific requirements is our forte. Our Board Certified radiologists offer preliminary, final and subspecialty reports 24/7/365. Turnaround times are set to match your needs. Our technical support center provides state of the art PACS/RIS and communication technology, which securely integrates with your current Information Systems.


Teleconsult pathologists offer services ranging from remote reporting of cyto- and histological cases, to lab design and quality assurance programs. We support the most basic lab set ups with second opinions and on-line consultations, and connect more advanced labs to our web based telepathology platform for routine reporting of diverse cases.


Our telemicrobiology services are offered by Dutch and UK Board Certified clinical microbiologists with sub-specialties in the fields of general microbiology, bacteriology, virology, parasitology, mycology, molecular diagnostics and epidemiology. Our clinical microbiologists are mainly active in clinical hospital settings, keeping them closely connected and in tune with daily clinical situations and challenges. This creates affinity with remote cases and ensures the up-to-date knowledge our customers require.

Locum Placement

Our recruitment division recruits certified radiologists, pathologists and micro biologists for part time and full time positions. In our 15 year history we successfully recruited and placed medical specialists in over 60 hospitals and clinics across the globe

Screening & Trials

From its worldwide network of Board Certified medical specialists, TeleConsult creates subspecialty teams for specific screening and clinical trial assignments. In 2012 TeleConsult’s dedicated breast radiologists were selected by the Dutch Breast Cancer Screening program to interpret its screening mammography studies.

We are hiring

We recruit, select and place sub-specialty, EU educated and certified radiologists, pathologists and microbiologists for short and long term positions. Our reputation has been built on a foundation of providing highly skilled doctors and the following core values: Professionalism, Value for money, Quality, Reliability and Integrity. Interested in joining our team? Register now!

Specialist care at your fingertips

Whether you are a hospital  department, diagnostic center or laboratory, Teleconsult doctors and IT experts bring optimal efficiency to your  workflow. A thorough analysis of your current situation, needs and requirements results in a balanced work flow management plan.

Teleconsult does not have any volume requirement and you are in full control to decide when to outsource studies to a Teleconsult doctor. To find out how your clinic or department will benefit from working with Teleconsult Europe, please contact us.


  • Balance on- and off site tasks




About Teleconsult

Founded in 2007 by Dutch radiologists, TeleConsult Europe (TCE) offers radiology services to hospitals, clinics, diagnostic centers, laboratories, medical services companies and the Dutch Government.

TCE’s mission is to provide its customers with tailored telemedicine solutions. Since its inception, TCE carefully listened to wishes and needs of its clients. This resulted in an array of interchangeable services providing radiology and pathology departments with high quality, cost efficient, flexible on- and off-site solutions.

Today TCE’s solutions consist of a combination of an on-site physician workforce, teleradiology, telepathology, and IT services. Our Western Board certified radiologists and pathologists perform reading services for a broad array of institutions varying from a 24/7 emergency reading service for hospitals and clinics, to screening services for the famous Dutch Breast Cancer Screening Program.

The primary objective of our highly trained physicians and staff is to enable our clients to provide optimal patient care and diagnostic services by placing quality and value first. Our synergetic modules provide tailored services to hospitals, clinics and imaging centers at any location on the globe. Whether you need an on-site physician, reports through telemedicine or a combination of both, we help you to realize an optimal and cost efficient workflow.

New study finds interruption of radiation therapy risks cancer recurrence

Missing 2 appointments of radiotherapy may impair tumor control, particularly for head and neck cancers.

Cancer patients who miss two or more radiation therapy sessions have a worse outcome than fully compliant patients, investigators at Montefiore Einstein Center for Cancer Care (MECCC) and Albert Einstein College of Medicine's NCI-designated Albert Einstein Cancer Center have found. The study, published in theInternational Journal of Radiation Oncology • Biology • Physics, suggests that this noncompliance to scheduled treatments may represent a new behavioral biomarker for identifying high-risk patients who require additional interventions to achieve optimal care outcomes.

The study evaluated 1,227 patients scheduled for courses of external beam radiation therapy for cancers of the head and neck, breast, lung, cervix uterus or rectum from 2007 to 2012. Two hundred twenty six of these patients (22 percent) were noncompliant (i.e., they missed two or more scheduled radiation therapy appointments). All patients eventually completed the radiation therapy course planned for them.

The radiation therapy course for noncompliant patients was prolonged for an average of one week compared with compliant patients. Nevertheless, 16 percent of noncompliant patients later experienced a recurrence of their cancers versus only a 7 percent recurrence rate for compliant patients.

"This study shows that the health of our patients can improve only when a course of treatment is completed in the prescribed period of time," said Madhur Garg, M.D., clinical director, Department of Radiation Oncology, MECCC and professor of clinical radiation oncology at Einstein. "These findings should serve as a wakeup call to physicians, patients and their caregivers about the critical need to adhere to a recommended treatment schedule."

Prolonging radiation therapy for head and neck cancer or cervical cancer impacted tumor control and overall survival at the greatest rate, at one percent per day, however this negative impact was seen in all cancers studied. This is attributed to tumor repopulation, which can accelerate after treatment initiation.

"We previously conducted a study that demonstrated a statistically significant relationship between lower socioeconomic status and non-compliance," said Nitin Ohri, M.D., attending physician, MECCC and assistant professor of radiation oncology at Einstein. "A Multivariable Cox proportional hazard model was informed by this prior study and helped us adjust for demographic variables like age, race, ethnicity and socioeconomic status."

As an outcome result of this study, management of mood disorders, patient navigator programs and increasing assistance with transportation are being evaluated at Montefiore as interventions that might improve patient care outcomes and close disparities among vulnerable populations.

Powered By | Full Text RSS Feed

'No evidence that CT scans, X-rays cause cancer'

Researchers conclude there is no proof that low-level radiation from medical imaging - such as X-ray and computed tomography scans - causes cancer. They say it is time to throw out an unproven, decades-old theoretical model that has led many people - doctors and regulators included - to believe otherwise.

Writing in the American Journal of Clinical Oncology, the researchers describe how the linear no-threshold model (LNT) - first proposed over 70 years ago - is used to estimate cancer risks from low-dose radiation, such as medical imaging.

But - say James Welsh, a radiation oncology professor in the Stritch School of Medicine at Loyola University, Chicago, IL, and colleagues - risk estimates based on the LNT model are only theoretical, and, as yet, "have never been conclusively demonstrated by empirical evidence."

They say persistent use of the LNT model by regulators and advisory bodies leads to unfounded fears and money being wasted on unnecessary safety measures.

As a result, many doctors are averse to recommending and using the most appropriate imaging procedures for their patients, and many patients are unnecessarily scared to undergo them.

Model ignores that human body repairs low-dose radiation damage

The LNT model maintains there is no safe dose of radiation - no matter how low the dose. It says you can work out the cancer risk of very low-dose radiation exposure by simply continuing in a straight line from the well-established, undisputed effects of high-dose radiation.

But such a model ignores the fact that the human body is able to repair damage caused by low-dose radiation - something that has evolved over millennia in humans and other organisms that are continually exposed to naturally occurring radiation in the environment. The authors note:

"We are literally bathed every second of every day in low-dose radiation exposure due to natural background radiation, exposures that vary annually from a few mGy to 260 mGy, depending upon where one lives on the planet."

They go on to explain how no associated health effects as a result of being exposed to this background radiation have been documented anywhere in the world.

In fact, people in countries like the US are living longer than ever - likely because of improvements in medical care that involve exposure to radiation from diagnostic equipment - e.g. X-rays or computed tomography (CT) scans - at doses well below those of the background radiation.

In their paper, the authors describe how they revisited the studies - from over 70 years ago - that led to widespread use of the LNT model.

Low-dose risks are not an extrapolation of high-dose risks

The studies - published in the 1940s - exposed fruit flies to various doses of radiation, but not very low doses. Nevertheless, they concluded that to estimate the risk of those effects occurring at low doses, you simply continued in a straight line down the plot result from the higher-dose experiments.

When scientists carried out the same experiments on fruit flies in 2009 - using low doses of radiation - they did not find the results to be as predicted by the original studies.

Also, note the authors, studies of human populations exposed to radiation - including nuclear bomb survivors - have never conclusively shown that low-dose radiation increases cancer risk.

They urge people to vigorously challenge any claim that low-dose radiation from medical imaging is known to cause cancer.

To back such claims only "serves to alarm and perhaps harm, rather than educate," they note, as they conclude that the LNT model "should finally and decisively be abandoned."

Meanwhile, Medical News Today recently learned how scientists have discovered a surprising new clue to how cancer tumors form. It appears that a small minority of cancer cells extend "cellular cables" to draw in nearby cells - including a lot of healthy cells - into the tumor.

Powered By | Full Text RSS Feed

New heart scanning technique to reduce radiation risk for patients

A new technique promises to reduce the radiation risk for patients and staff, a study recently published in the Journal of Nuclear Cardiology shows1. Researchers who led the study at the Nuclear Medicine Department at Central Manchester University Hospitals believe that these findings will offer a more efficient and sustainable approach to delivering myocardial perfusion imaging. The department provides scanning for patients with heart conditions across the North West region and performed approximately 2300 scans in 2015.

Coronary artery disease (CAD) is the UK's largest killer and those living in the North West are more likely to die from the condition than anywhere else in England2. In patients with CAD, the arteries that supply the heart muscle with oxygen-rich blood become narrowed by a gradual build-up of fatty deposits. Eventually this may block the delivery of oxygen to the heart causing permanent damage to the heart, known as a heart attack. A myocardial perfusion scan is a non-invasive scan that gives doctors information about the blood supply to the heart muscle. It is one of the tests that have an important role in the management of patients with CAD, with thousands of scans performed across the UK every year.

A myocardial perfusion scan uses a short-lived radioactive tracer that is injected into a vein in a patient's arm and accumulates in the heart muscle. The radioactive tracer emits gamma rays and the position of these is detected using a gamma camera. The gamma camera has a lead filter (collimator) attached to the front of the camera to control the amount of radioactivity it detects.

In the published study, a perspex model filled with water was used to mimic the distribution of radioactive tracer from a patient heart scan. This approach allows researchers to evaluate alternative techniques without unnecessary radiation risk for patients.

The researchers compared the quality of images using alternative collimators, that allow more radioactivity through to the camera, against standard collimators. The benefit of the alternative collimators is that less radioactive tracer can be used and the images can be acquired in less time. However the images produced have less fine detail.

In this study, the researchers found that by using an advanced image processing technique called "resolution recovery" they were able to create images using the alternative collimator, which were of similar or better quality than the standard procedure. This new approach reduces the amount of radioactive tracer required and will lead to a reduction of patient radiation dose by 35-40%.

Ian Armstrong, Principal Physicist in Nuclear Medicine, said "We undertake considerable research into optimising nuclear medicine techniques for the benefit of our patients and to also help our staff work more efficiently. As physicists, we have a responsibility to drive efficiencies in the way our departments work. As well as reducing the radiation risk, we hope that this new approach will enable us to provide the same high-quality scans using less radioactive tracer."

"The next step is to undertake a clinical trial to compare the effectiveness of the new procedure against standard practice in patients. We hope to start recruiting patients to participate in this trial in spring 2016."

Powered By | Full Text RSS Feed